Pet Cancer Therapeutics Market Size, Share, Growth and Report 2024-2032
The latest report by IMARC Group, titled “ Pet Cancer Therapeutics Market Report by Therapy (Chemotherapy, Radiation Therapy, Immunotherapy, Combination Therapy, and Others), Animal Species (Cats, Dogs, and Others), Cancer Type (Lymphoma, Mast Cell Cancer, Melanoma, Mammary and Squamous Cell Cancer, and Others), End User (Veterinary Hospitals and Clinical Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Region 2024-2032" , The global pet cancer therapeutics market size reached US$ 295.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 635.9 Million by 2032, exhibiting a growth rate (CAGR) of 8.5% during 2024-2032. Factors Affecting the Growth of Pet Cancer Therapeutics Industry: Increasing Pet Ownership: The global pet cancer therapeutics market is experiencing substantial growth due to the rising trend of pet ownership. As more individuals choose to bring pets into their homes, the demand for comprehensive healthcare, including canc